Sanofi epinephrine device guides users with voice and written instructions

Sanofi ($SNY) this week gained FDA approval for a new credit card-sized epinephrine/adrenaline injection device that gives aural and written instructions to users. The Auvi-Q combination device is about as thick as a cell phone and designed to treat allergic reactions, according to The Associated Press. It even retracts the needle to minimize accidental sticking. The treatment is meant to counter severe allergic reactions to things like medications, bee stings and foods like nuts or shellfish, the story notes. Story

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,